ENIMMUNE CORPORATION

ENIMMUNE focuses on clinical trials, new drug commercialization, and strategic partnerships with research-based pharmaceutical companies. By integrating resources across the pharmaceutical ecosystem, we accelerate the development and market access of innovative drugs and vaccines. Through technology transfer and collaboration with academia, research institutes, and clinical trial centers, we aim to address unmet medical needs and improve global health.